Annals of the rheumatic diseases, vol 81, iss 11 van Vollenhoven, R F, Kalunian, K C, Dörner, T, Hahn, B H, Tanaka, Y, Gordon, R M, Shu, C, Fei, K, Gao, S, Seridi, L, Gallagher, P, Lo, K H, Berry, P & Zuraw, Q C 2022, ' Phase 3, multicentre, randomised, placebo-controlled study evaluating the efficacy and safety of ustekinumab in patients with systemic lupus erythematosus ', Annals of the Rheumatic Diseases, vol. 81, no. 11, 222858, pp. 1556-1563 . https://doi.org/10.1136/ard-2022-222858 Annals of the Rheumatic Diseases, 81(11):222858, 1556-1563. BMJ Publishing Group Annals of the rheumatic diseases, 81(11):222858, 1556-1563. BMJ Publishing Group